Recent studies have shown that DLEU2 is upregulated in many human cancers, such as non-small cell lung cancer (NSCLC) 47, esophageal adenocarcinoma 48, and osteosarcoma 49. Here, DLEU2 is linked to non-small cell lung carcinoma.